ArticleJournal of clinical medicine2020
First Multi-Center All-Comers Study for the Aquablation Procedure.
Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 3 syntheses or guidelines pooled it, 44 citations in OpenAlex.
- Ejaculatory function after robotic waterjet ablation for the treatment of benign prostatic hyperplasia: a systematic review.International journal of impotence research · 2026Pooled it
- Complication Profile and Safety Outcomes of Aquablation in the Management of BPH.Medicina (Kaunas, Lithuania) · 2025Pooled it
- Are all procedures for benign prostatic hyperplasia created equal? A systematic review on post-procedural PSA dynamics and its correlation with relief of bladder outlet obstruction.World journal of urology · 2022Pooled it
- Review
- Letter to the Editor: The impact of prostate size on outcomes of aquablation-a prospective study.World journal of urology · 2026Article
- The impact of prostate size on outcomes of aquablation: a prospective study.World journal of urology · 2026Article
- Quality-of-life outcomes following Aquablation in men with poor initial quality of life: pooled analysis of five international studies.Prostate international · 2026Article
- Aquablation for benign prostatic hyperplasia: real-world prostate size relevance and bleeding events across 6 years.BJU international · 2026Article
- Management of clinical failure after minimally invasive surgical therapies (MIST) for BPH: repeat MIST versus resection, enucleation or ablation-a narrative review from EAU endourology.World journal of urology · 2026Review
- A Narrative Review of Robotic Aquablation in Benign Prostatic Hyperplasia Care: Where We Are Now.Cureus · 2025Review
- Research progress on ejaculatory function preservation in minimally invasive surgical treatments for benign prostatic hyperplasia: a narrative review.Translational andrology and urology · 2025Review
- Aquablation versus HoLEP: Propensity score matching analysis of functional outcomes and ejaculation preservation.Investigative and clinical urology · 2025Article
- Application of robotics in the treatment of benign prostatic hyperplasia: a narrative review.Prostate international · 2025Review
- Treatment Algorithm for Management of Benign Prostatic Obstruction: An Overview of Current Techniques.Life (Basel, Switzerland) · 2023Review
- Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results.The Journal of urology · 2023Article
- Aquablation in men with benign prostate hyperplasia: A systematic review and meta-analysis.Current urology · 2023Article
- Surgical Complications in the Management of Benign Prostatic Hyperplasia Treatment.Current urology reports · 2022Review
- Learning curve in aquablation: an international multicenter study.World journal of urology · 2022Article
- Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results.BJUI compass · 2022Article
- Evolution of AquablationVR-From innovation to establishment.Turkish journal of urology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 5 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Waterjet-based prostate resection (Aquablation procedure) is an increasingly recognized treatment for symptomatic benign prostatic hyperplasia (BPH). We confirmed the safety and effectiveness of the Aquablation procedure in the commercial setting in 178 men at five sites. The mean prostate volume was 59 cc. The procedure time averaged 24 min and total anesthesia duration was 50 min. The International Prostate Symptom Score (IPSS) decreased from 21.6 at the baseline to 6.5 at the 12-month follow-up, a 15.3-point improvement (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.